Earth Science Tech Inc. (OTC: ETST) has emerged as a diversified healthcare holding company with a strategic focus on shareholder value, as evidenced by its sustained share repurchase program and simultaneous expansion of its healthcare platform. The company, which operates across telemedicine, compounding pharmacies, clinical support services and healthcare fulfillment, has been actively reducing its share count through buybacks documented in SEC filings.
According to Earth Science Tech's most recent Form 10-Q for the quarter ended December 31, 2025 (https://ibn.fm/Gm12j), the company repurchased 1,143,000 common shares during that quarter alone. Over the nine months ended December 31, 2025, Earth Science Tech repurchased a total of 3.7 million shares, spending approximately $647,000. This aggressive buyback program has reduced the company's outstanding shares, a factor that often receives as much attention from OTC market investors as revenue growth or acquisition activity.
Management continues to emphasize shareholder value through balance-sheet management alongside acquisitions and operating growth. The company's evolution into a diversified healthcare holding company has been paired with financial discipline, as indicated by the share repurchases. Earth Science Tech is scheduled to present to investors at the Planet MicroCap Las Vegas 2026 conference in June, which may provide further insight into its strategy.
The share repurchase program is particularly noteworthy for investors evaluating companies on the OTC market, where share structure can significantly impact stock performance. By reducing the number of shares outstanding, Earth Science Tech is effectively increasing the ownership stake of existing shareholders without additional dilution. This move signals confidence from management in the company's valuation and future prospects.
Earth Science Tech's healthcare operations span multiple high-growth sectors, including telemedicine and pharmacy services, which may benefit from ongoing trends in healthcare accessibility and personalized medicine. The company's ability to combine operational expansion with financial engineering could attract attention from value-oriented investors.
For more information on Earth Science Tech, visit the company's newsroom at https://ibn.fm/ETST.
